GREAT POINT PARTNERS LLC 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:40 pm Sale | 2024-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | GREAT POINT PARTNERS LLC | 2,055,834 6.880% | -674,075 (-24.69%) | Filing |
| 2024-11-14 5:05 pm Sale | 2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | GREAT POINT PARTNERS LLC | 2,729,909 9.380% | -63,018 (-2.26%) | Filing |
| 2024-02-14 4:39 pm Unchanged | 2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | GREAT POINT PARTNERS LLC | 2,792,927 9.990% | 0 (Unchanged) | Filing |
| 2023-10-12 4:04 pm Purchase | 2023-10-02 | 13G | VistaGen Therapeutics, Inc. VTGN | GREAT POINT PARTNERS LLC | 2,792,927 9.990% | 2,792,927 (New Position) | Filing |